ConductScience.org, home

Paper3698035

Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.

von Roenn JH and 3 others. Cancer Res, 1986. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Papers, record 3698035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3698035

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
PubMed
Journal
Cancer Res
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
4.45
iCite
Revised in PubMed
2006-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1von Roenn JHJ H
2Kheir SMS M
3Wolter JMJ M
4Coon JSJ S

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AneuploidyMajor topic
DNA, NeoplasmMajor topic
Flow CytometryMajor topic
MelanomaMajor topic
Nevus, PigmentedMajor topic
Skin NeoplasmsMajor topic
Follow-Up Studies
Humans
Prognosis
Retrospective Studies
Skin Ulcer

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
36276131Causes, consequences and clinical significance of aneuploidy across melanoma subtypes.Front Oncol2022https://conductscience.org/library/papers/36276131PubMed
9667668Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.Br J Cancer1998https://conductscience.org/library/papers/9667668PubMed
8304780Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.Arch Dermatol Res1993https://conductscience.org/library/papers/8304780PubMed
8129491Surgical management and prognostic factors in patients with subungual melanoma.Ann Surg1994https://conductscience.org/library/papers/8129491PubMed
7626566DNA index and S phase fraction in uveal malignant melanomas.Br J Ophthalmol1995https://conductscience.org/library/papers/7626566PubMed
3355269Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.Ann Surg1988https://conductscience.org/library/papers/3355269PubMed
3219270The flow cytometry of melanocytic skin lesions.Br J Cancer1988https://conductscience.org/library/papers/3219270PubMed
3192729DNA content and MHC class II antigen expression in malignant melanoma: clinical course.J Clin Pathol1988https://conductscience.org/library/papers/3192729PubMed
1911224DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.Br J Cancer1991https://conductscience.org/library/papers/1911224PubMed
1520590Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.Br J Cancer1992https://conductscience.org/library/papers/1520590PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3698035

GET https://conductscience.org/api/papers/v1/3698035/authors